The generic drug maker Mylan desires to put to rest the potential merger with Teva Pharmaceuticals which was highly speculated. Teva Pharmaceuticals is an acknowledged international pharmaceutical company which develops, manufactures, and market different generic and branded human medicines, active pharmaceutical ingredients, and medical disposables among others.
Mylan stated that the deal, despite being promising, lacks satisfactory industrial logic. The company emphasized that an adversity is likely to be met in the attempt to win the anti-trust clearances should the deal be pursued.
Also read: United Technologies Keeps Eye on a Breakup